Drug target optimization in chronic myeloid leukemia using innovative computational platform. (2015)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/srep08190
PubMed Identifier: 25644994
Publication URI: http://europepmc.org/abstract/MED/25644994
Type: Journal Article/Review
Volume: 5
Parent Publication: Scientific reports
ISSN: 2045-2322